Glucose Tablets For Low Blood Sugar Market Report: Sales Volume, Market Share, Leading Brands & Market Trends

TRUEplus is the best-performing glucose tablets for low blood sugar brand in July 2026, moving 13,000 units across 6 ASINs for 59.1% of Top 10 volume. BOOST follows with 4,000 units (18.2%), ahead of Toplux on 3,000 units (13.6%).

With 5 brands splitting the Top 10 and 90.9% of volume sitting with three of them, this is a concentrated shelf — the leaders hold multiple listings or one very high-velocity ASIN, so a new entrant competes against established review moats rather than an open field. Average selling prices among the leaders run from $12.66 to $42.30, which frames the price band a competing listing has to justify.

Based on July 2026 data, this shortlist surfaces the two kinds of ASIN worth keeping an eye on — the ones that just broke into the Top 10, and the ones growing fastest month over month. Specifically, 2 ASINs forced its way in: B00FEKDPF8 booked 1K units at $9.29, with ▲ 11.1% MoM change. On the growth side, B01F69QD5U leads positive momentum with ▲ 100.0% MoM growth on 2K units.

The two signals carry different weight. A fresh entrant means share has already changed hands — an incumbent gave up its place to make room, so any competitive set drawn up a month ago is now out of date. A steep growth rate works as the earlier warning: it marks demand that is still compounding, usually a month or two before the ranking catches up to it.